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RNA splicing is an increasingly recognized regulator of immunity. Here, we demonstrate
that after Mycobacterium tuberculosis infection (mRNA) il12rb1 is spliced by dendritic
cells (DCs) to form an alternative (mRNA) il12rb1tm that encodes the protein
IL-12R1TM. Compared with IL-12R1, IL-12R1TM contains an altered C-terminal
sequence and lacks a transmembrane domain. Expression of IL-12R1TM occurs in
CD11c+ cells in the lungs during M. tuberculosis infection. Selective reconstitution of
il12rb1/ DCs with (mRNA) il12rb1 and/or (mRNA) il12rb1tm demonstrates that
IL-12R1TM augments IL-12R1-dependent DC migration and activation of
M. tuberculosis-specific T cells. It cannot mediate these activities independently of
IL12R1. We hypothesize that M. tuberculosis-exposed DCs express IL-12R1TM to
enhance IL-12R1-dependent migration and promote M. tuberculosis–specific T cell
activation. IL-12R1TM thus represents a novel positive-regulator of IL12R1dependent DC function and of the immune response to M. tuberculosis.
CORRESPONDENCE
Andrea M. Cooper:
acooper@trudeauinstitute.org
Abbreviations used: BMDC,
BM-derived DC; DT, diphtheria toxin; DTR, DT receptor;
eGFP, enhanced GFP; EMSA,
electromobility shift assay;
MLN, mediastinal LN.

The control of M. tuberculosis infection occurs
through an acquired antigen-specific CD4+
T cell response and the IL12B gene is essential
to this response (Cooper et al., 2007; Cooper,
2009). Although IL-12 plays an expected role
in modulating Th1 responses to M. tuberculosis,
we have also shown that IL-12(p40)2 is
required for DCs to migrate in response to
chemokines after exposure to mycobacterial
and other pathogenic stimuli (Khader et al.,
2006; Robinson et al., 2008). That this migration may be important in initiating T cell responses is suggested by the observation that
depletion of CD11c+ cells before infection delays T cell activation and influences the outcome of infection (Tian et al., 2005).
IL-12 family members mediate their biological activities through specific, high-affinity
dimeric receptors. All these receptors share
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IL-12R1, a 100-kD glycosylated protein that
spans the plasma membrane and serves as a
low-affinity receptor for the IL-12p40 subunit
of IL-12 family members (Chua et al., 1994,
1995); coexpression with IL-12R2 or IL-23R
results in high-affinity binding of IL-12 and
IL-23, respectively, and confers biological
responsiveness to these cytokines (Presky et al.,
1996; van Rietschoten et al., 2000; Parham
et al., 2002). Polymorphisms in IL12B or
IL12RB1 are associated with psoriasis (Capon
et al., 2007), atopic dermatitis, and other allergic
phenotypes (Takahashi et al., 2005) and,
importantly, nonfunctional IL12RB1 alleles
© 2010 Robinson et al. This article is distributed under the terms of an
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six
months after the publication date (see http://www.rupress.org/terms). After six
months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons
.org/licenses/by-nc-sa/3.0/).
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RESULTS
IL-12R1 is required for M. tuberculosis–induced
DC migration and function
As il12b is required for DC migration in response to M. tuberculosis (Khader et al., 2006), it was necessary to determine
whether il12rb1, which encodes the receptor for IL-12
(Presky et al., 1998; Wang et al., 1999; Oppmann et al., 2000),
is expressed by DCs in response to M. tuberculosis and if it is
required for subsequent DC migration and T cell priming. To
do this, we delivered M. tuberculosis via the intratracheal route
and found that the frequency of CD11c+ cells expressing
IL-12R1 in the lungs increases 3 h after delivery (Fig. 1 A);
BM-derived DCs (BMDCs) also respond to M. tuberculosis by
increasing the expression of IL-12R1 on CD11c+ cells
(Fig. 1 B). To test if il12rb1 was required for DC migration
after mycobacterial stimulation, we generated an immature
population of il12rb1/ BMDCs and tested its ability to
migrate toward the homeostatic chemokine CCL19 using a
previously established method (Khader et al., 2006). il12rb1/
DCs are morphologically and phenotypically similar to
C57BL/6 DCs (unpublished data); however, in an in vitro
transwell assay, il12rb1/ DCs had a significantly lower
migratory response toward CCL19 after exposure to varying

Figure 1. IL-12R1 is required for M. tuberculosis–induced DC migration. (A) M. tuberculosis was instilled into the trachea of C57BL/6 mice, and 3 h
later the frequency of CD11c+IL-12R1+ cells in the lungs was determined. Dot plots are representative of four mice per condition; this experiment was performed twice with two separate BM preparations. (B) C57BL/6 BMDCs were exposed to M. tuberculosis or media alone, and 3 h later the frequency of
CD11c+IL-12R1+ cells was determined. Dot plots represent the same BMDC preparation stimulated with either condition and are representative of three
separate experiments. (C) BMDCs generated from C57BL/6 or il12rb1/ mice were assayed for their ability to migrate to CCL19 in a transwell assay after a
3-h exposure to M. tuberculosis (CI, number moved in response to CCL19/number moved to media alone). Data points in C represent mean and SD of triplicate
values and are representative of three separate experiments; for the difference between CI induced in C57BL/6 relative to il12rb1/ DCs, *, P < 0.05; **, P <
0.005, as determined by Student’s t test. (D–F) M. tuberculosis/CFSE was instilled via the trachea into C57BL/6, il12b/, il12rb1/, or il12rb2/ mice. 18 h
later, the frequency (D and E) and total number of CD11c+CFSE+ cells in the draining MLN were counted. The data points in E and F represent the mean and SD
of combined data from four mice per group (F) and are representative of two separate experiments; for the difference between percentage and/or number of
CD11c+CFSE+ cells found in C57BL/6 mice relative to il12b/ or il12rb1/ mice, *, P < 0.05; ***, P < 0.0005, as determined by Student’s t test.
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predispose to mycobacterial susceptibility (Altare et al., 1998;
de Jong et al., 1998; Filipe-Santos et al., 2006; Fortin et al.,
2007). Thus, understanding how IL-12R1 expression and
IL-12R1–dependent signaling is regulated has important
implications for tuberculosis and may impact other diseases.
Given that CD11c+ cells contribute to the control of
M. tuberculosis infection (Tian et al., 2005) and that IL-12(p40)2
is required for their migration in response to pathogenic stimuli
(Khader et al., 2006; McCormick et al., 2008; Robinson et al.,
2008), we sought to determine if IL-12R1 is required for DC
migration after exposure to this organism. In the course of
these investigations we not only confirmed this hypothesis but
also discovered that DCs express both IL-12R1 and a novel
IL-12R1 splice variant (IL-12R1TM) in response to
M. tuberculosis. This splice variant can be seen at the mRNA
level in CD11c+ cells from the lungs of M. tuberculosis–infected
mice and as a protein in the membrane of DCs. Importantly,
we have determined that IL-12R1TM functions to enhance IL-12R1–dependent DC migration and promote
CD4+ T cell activation. This finding not only impacts our understanding of DC migration and IL-12R1–dependent
mycobacterial immunity it also reveals a previously unknown
positive regulator of IL-12R1–dependent events.
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A reduced frequency of il12rb1-sufficient CD11c+ cells
in the lung delays the activation of M. tuberculosis–specific
T cells
CD4+ T cell responses to M. tuberculosis antigens are initiated
in the MLN (Gallegos et al., 2008; Reiley et al., 2008;
Winslow et al., 2008; Wolf et al., 2008). Therefore, we speculated that a delay in CD11c+ cell migration would delay
the activation of M. tuberculosis–specific CD4+ T cells. To
test this idea, we used diphtheria toxin (DT) to specifically
deplete il12rb1+/+ CD11c+ cells from BM chimeras that contained DT receptor–positive (DTR+) C57BL/6 CD11c+
cells and DTR-negative il12rb1/ CD11c+ cells and measured M. tuberculosis–specific T cell activation to intratracheal
administration of M. tuberculosis and antigen. The chimeras
were generated by reconstituting lethally irradiated C57BL/6
mice with 25% il12rb1/ and 75% Itgax-DTR/eGFP BM
(DTR:il12rb1/ mice) or, as a control, 25% C57BL/6 and
75% Itgax-DTR/EGFP BM (DTR:WT mice). The ItgaxDTR/eGFP mice are transgenic for a simian DTR fused to
an enhanced GFP (eGFP) that is under control of the Itgax
(or CD11c) promoter. Upon DT administration, CD11c+
cells containing this transgene are transiently depleted in most
tissues (Jung et al., 2002).
In control DTR:WT mice injected with saline, the
majority of CD11c+ cells are GFP+, demonstrating reconstitution of the lung with DTR-expressing cells (Fig. 2 A).

Figure 2. The presence of il12rb1/ DCs in the lung associates
with impaired activation of M. tuberculosis-specific T cells in the
draining MLN. Chimeras comprising 75% Itgax-DTR/EGFP:25% il12rb1+/+
or 75% Itgax-DTR/EGFP:25% il12rb1/ were injected with either PBS (A
and F) or DT (B–E and G–J). 12 h later, the frequency of CD11c+ GFP+ and
CD11c+ GFP cells remaining in the lungs after PBS injection (A and F)
or DT injection (B and G) was determined. Gating based on CD11c+ GFP+
or CD11c+ GFP cells demonstrated the level of IL-12R1 surface expresJEM VOL. 207, March 15, 2010

sion (A and F). DT-injected mice subsequently received 1.5 × 106 CFSE-labeled
ESAT6-specific CD4+ T cells i.v. and 1 µg ESAT61-20/50 ng irradiated M.
tuberculosis via the trachea. 12 h later, the frequency of CFSE+CD4+ cells
in the draining MLN (C and H) and expression levels of the activation
markers CD69 (D and I) and CD44 (E and J) determined by flow cytometry.
The data points in K and L represent the CD44 (K) and CD69 (L) data from
5 mice per group that received either 1 µg or 10 ng ESAT1-20 peptide with
irradiated M. tuberculosis and are representative of two separate experiments with 3–4 mice per group; for the difference in %CD44hi and
%CD69+ ESAT-specific CD4+ cells between the indicated groups,
*, P < 0.05; **, P < 0.005, as determined by Student’s t test.
593

Downloaded from jem.rupress.org on September 13, 2011

concentrations of M. tuberculosis compared with C57BL/6
controls (Fig. 1 C). To determine if this was also true in
vivo, we administered a mixture of M. tuberculosis and CFSE
to il12b/, il12rb1/, il12rb2/, and C57BL/6 mice via the
trachea and the number of CFSE+ CD11c+ cells in the draining mediastinal LN (MLN) was determined 18 h later.
Although nonmanipulated mice of all genotypes had similar
amounts of CD11c+ cells in their lung and MLN (not
depicted), we consistently observed a lower frequency (Fig. 1,
D and E) and fewer numbers (Fig. 1 F) of CD11c+CFSE+ cells
in the MLN of il12b/ and il12rb1/ mice after administration via the trachea of M. tuberculosis and CFSE. This was
not true of il12rb2/ mice, further supporting a role for
IL-12(p40)2, and not IL-12p70, in DC migration (Khader
et al., 2006). These results demonstrate that il12rb1 is required for M. tuberculosis–induced CD11c+ cell migration from
the lung to the draining MLN.

Published March 8, 2010

IL-12(p40)2 initiates nuclear accumulation of NF-B in DCs
We wished to better understand the mechanism by which
IL-12R1–dependent signaling modulates DC chemotaxis
after exposure to M. tuberculosis. Lower levels of CCR7 (the
receptor for CCL19) do not account for this result, as surface
expression of CCR7 is similar between activated WT and
il12rb1/ BMDCs (unpublished data). To determine if any
intracellular signaling pathways that influence DC migration
were altered in il12rb1/ DCs, we measured the phosphorylation levels of NF-B, SAPK/JNK, p38 MAP kinase, and
STAT3 in these cells after stimulation with M. tuberculosis.
We observed that stimulation of C57BL/6 DCs increases
phospho-NF-B levels above those of unstimulated controls
(Fig. 3, A and B). However, we consistently observed that
levels of phospo-NF-B were lower in il12rb1/ DCs compared with WT DCs at several time points, despite equivalent levels of total NF-B (Fig. 3, C and D). No differences
in phospho-SAPK/JNK, p38 MAP kinase, and STAT3 were
observed between WT and il12rb1/ DCs (unpublished data).
These data suggest that NF-B–dependent processes are
compromised in il12rb1/ DCs
Because NF-B phosphorylation was defective in il12rb1/
DCs, we reasoned that NF-B binding should be enhanced
when DCs are stimulated via IL-12R1. To test this hypoth594

esis, we exposed il12b/ BMDC to M. tuberculosis and/or
IL-12(p40)2 for 1 h, and, using electromobility shift assay
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Both GFP+ and the subset of GFP CD11c+ cells are
il12rb1+/+ and express basal levels of IL-12R1 on their surface (Fig. 2 A). Upon injection of DT, the frequency of GFP+
CD11c+ cells drops 12-fold (Fig. 2 B), resulting in an increased ratio of GFP to GFP+ CD11c+ cells. Treating the
DTR:il12rb1/ mice with DT resulted in a similar drop in
GFP+ CD11c+ cells (Fig. 2, F and G), and therefore a greatly
reduced frequency of il12rb1+/+ CD11c+ relative to il12rb1/
CD11c+ cells in the lungs of these mice.
To compare the relative T cell–activating ability of lungs
harboring a high frequency of il12rb1+/+ CD11c+ cells to
those with a low frequency, we measured the response of
antigen-specific cells in the MLN. To do this, we intravenously transferred 1.5 × 106 CFSE-labeled ESAT-specific
CD4+ T cells into DT-injected DTR:WT or DTR:il12rb1/
mice immediately before instillation via the trachea of
ESAT61-20 peptide and 1 µg of irradiated M. tuberculosis. 18 h
later, the frequency of ESAT-specific T cells (Fig. 2, C and H)
expressing markers of activation CD69 (Fig. 2, D and I) and
CD44 (Fig. 2, E and J) in the draining MLN was determined.
The frequency of ESAT6-specific T cells that expressed a
high level of CD44 (Fig. 2 K) and CD69 (Fig. 2 L) in response
to two different doses of antigen within the 18 h of the experiment was significantly lower in the mice with a reduced
frequency of il12rb1+/+ CD11c+ cells. Thus, an increase in
the ratio of il12rb1/ to il12rb1+/+ DCs in the lungs is associated with impaired activation of antigen-specific T cells in
the draining MLN. These data demonstrate that il12rb1 expression in CD11c+ cells within the lung is required for
M. tuberculosis–induced DC migration and induction of T
cell activation in vivo.

Figure 3. NF-B signaling is impaired in il12rb1/ DCs and can be
promoted by IL-12(p40)2. (A-D) BMDCs generated from C57BL/6 and
il12rb1/ mice were exposed to M. tuberculosis (B and D) or media alone
(A and C) for the indicated times. After this period, cells were harvested
under nondenaturing conditions and levels of total NF-B p65 (open bars)
and phospho-NF-B p65 (closed bars) were determined by ELISA. Shown
are the light absorbance values (A450) from one experiment that is representative of two experiments with separate BMDC preparations. (E) BMDCs
were generated from il12b/ mice and exposed to media alone, M. tuberculosis, IL-12(p40)2, or both M. tuberculosis and IL-12(p40)2. 1 h later,
nuclear extracts of the treated cells were isolated and EMSA of NF-B consensus sequence-binding proteins was performed. Shown is a blot of NF-B
consensus sequence-binding proteins from DCs stimulated with media
alone (lanes 1 and 2), M. tuberculosis (lanes 3 and 4), both M. tuberculosis
and IL-12(p40)2 (lanes 5 and 6) or IL-12(p40)2 alone (lanes 7 and 8). The
absence () or presence (+) of a cold NF-B consensus probe was used to
determine the specificity of each band.
Splicing of il12rb1 alters DC migration | Robinson et al.
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BMDCs express (mRNA) il12rb1 and an (mRNA) il12rb1
alternative splice variant after exposure to M. tuberculosis
The expression of (mRNA) il12rb1 by DCs has not been
universally accepted because of an inability to reproducibly
detect this transcript (Grohmann et al., 1998). However,
given the influence of il12rb1 on DC migration (Figs. 1 and 2),
we reexamined (mRNA) il12rb1 expression in these cells.

The mouse il12rb1 gene is located on autosomal chromosome 8 and comprises 16 exons (Fig. 4 A; NCBI protein
database accession no. 16161). Upon transcription and intron
removal, exons 1–13 are translated into the extracellular
portion of the IL-12R1 protein, whereas exon 14 and
exons 15–16 are translated into the transmembrane and intracellular portions, respectively (Fig. 4 B). To determine the
transcription activity of this gene in DCs, we amplified cDNA
from BMDC cultures with a variety of primers spanning
different lengths of (cDNA) il12rb1 (Fig. 4 B). Amplification
with primers (P) recognizing the extracellular-encoding
region (P1–P2) resulted in an amplicon (Fig. 4 C; cDNA
from concanavalin-A–activated splenocytes is used as a positive control). Amplification of a more 3 region with primers
P3–P5 also resulted in a PCR product in both unstimulated
and stimulated DCs; however, under these amplification
conditions a second smaller band was also observable, but
only in DCs that had been stimulated with M. tuberculosis
(Fig. 4 C, arrow). This second band does not appear upon
amplification with primers that span the transmembraneencoding region (P3-P4). Sequencing both the larger and
smaller band amplified by primers P3–P5 revealed that the
larger product represents (mRNA) il12rb1 and that the smaller
product is identical, except for a 97-bp deletion (Fig. 4 D).
This deletion has two effects: (1) deletion of the transmembrane

Figure 4. DCs express an IL-12R1 alternative splice variant after exposure to M. tuberculosis. (A) The genomic position and organization of
the murine il12rb1 locus. Exons 1–16 are denoted e.1-e.16. (B) Upon transcription and intron removal, e.1-13 become the extracellular-encoding (EC)
portion of the IL-12R1 transcript, e.14 the transmembrane-encoding (TM) portion, and e15-16 the intracellular-encoding (IC) portion. Shown to the
right of the transcript are the relative positions of primers 1–5 (P1-P5;  indicates a forward primer and  indicates a reverse primer) used for amplification of IL-12R1 cDNA from the indicated cell populations (C). (D-E) Sequencing of the smaller amplicon of P3-P5 (indicated by arrow) reveals an IL12R1 alternative splice variant that contains both a 97-bp deletion and (E) a frameshift insertion that eventually produces a premature stop codon. This
experiment has been repeated three times with three separate BMDC preparations.
JEM VOL. 207, March 15, 2010
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(EMSA), compared the amount of NF-B consensus sequence-binding proteins in nuclear extracts of the treated
cells. il12b/ BMDCs were used for this experiment to
eliminate potential background NF-B activation from
endogenous IL-12(p40)2. Fig. 3 E demonstrates that the
addition of M. tuberculosis to DC cultures increases the
nuclear accumulation of NF-B over that seen in untreated
BMDCs (Fig. 3 E, compare lanes 1 and 3). IL-12(p40)2 was
also sufficient to increase the nuclear accumulation of NF-B
over that seen in untreated BMDCs (Fig. 3 E, compare lanes
1 and 7). The addition of both M. tuberculosis and IL-12(p40)2
synergistically augmented NF-B activation above that of
each stimulus alone (Fig. 3 E, compare lanes 3 and 7 to lane
5). Thus, our data demonstrate that IL-12(p40)2 is able to
stimulate NF-B nuclear migration in DCs. Consequently,
the failure of il12rb1/ DCs to migrate (Figs. 1 and 2)
associates with impaired NF-B–dependent gene activation.

Published March 8, 2010

sequence encoded by exon 14 and (2) a translational frame shift
that results in an early stop codon. This translational frame shift
also results in the loss of the Box1/2 signaling domains that are
found in the IL-12R1 protein (van de Vosse et al., 2003).
Both the nucleotide and deduced amino acid sequence of this
smaller band (Fig. 4 E) match that of a previously reported
alternative splice variant of the mouse IL-12R1 transcript
(Chua et al., 1995). Thus, DCs respond to M. tuberculosis
by expressing two species of (mRNA) il12rb1: a transmembrane-containing transcript (hereafter referred to as “(mRNA)
il12rb1”) and an alternatively spliced variant of (mRNA)
il12rb1 (hereafter referred to as “(mRNA) il12rb1tm”).

596

Human DCs respond to stimuli by splicing IL-12R1
After activation, human DCs increase surface expression of
IL-12R1 (Nagayama et al., 2000). Two isoforms of the
human IL-12R1 transcript are reported in publicly available
databases: full-length IL-12RB1 (isoform 1; Swiss-Prot ID
P42701-1) and a shorter isoform, missing the transmembrane
domain and with an altered C-terminal amino-acid sequence
that is the product of alternative splicing (isoform 2; SwissProt P42701-3; sequences available at http://www.uniprot.
org/uniprot/P42701; Fig. S3, A and B). To determine if human DCs splice the IL-12R1 transcript after stimulation in
a manner that is analogous to mouse DCs, we exposed monocyte-derived DCs to a variety of stimuli, some of which are

Figure 5. IL-12R1 Spectratype analysis of M. tuberculosis-activated
DCs. (A) C57BL/6 BMDCs were stimulated over a period of 6 h with media
alone or M. tuberculosis. Shown are representative IL-12R1 spectratype data
from these DCs before culture (0 h) and after 1.5, 3, or 6 h of culture. The
numbers adjacent to peaks of an individual IL-12R1 spectra indicate the
relative ratio of that peak’s area (the smaller peak representing IL-12R1TM)
to the area of the larger peak that represents IL-12R1. Spectra are representative of four BMDC cultures per condition; this experiment was performed
twice. (B) Denaturing Western blot analysis of the same cells to confirm
changing protein levels of IL-12R1 and IL-12R1TM; NIH/3T3 cells transfected with the indicated plasmid constructs served as positive controls; blots
were probed with polyclonal anti-IL-12R1.
Splicing of il12rb1 alters DC migration | Robinson et al.
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Kinetics of BMDC (mRNA) il12rb1tm expression
after exposure to M. tuberculosis
As (mRNA) il12rb1tm was induced in BMDCs by M. tuberculosis, we wished to quantify its expression; however, it
proved difficult to design a Taqman real-time PCR probe
that recognized (cDNA) il12rb1tm and not (cDNA) il12rb1.
Thus, to better quantify the kinetics of (mRNA) il12rb1tm
expression relative to (mRNA) il12rb1 in M. tuberculosis–
stimulated DCs, we developed a PCR-based assay hereafter
referred to as “IL-12R1 spectratype analysis.” IL-12R1
spectratype analysis is akin to TCR-CDR3 spectratype
analysis (Pannetier et al., 1993) and is described in Fig. S1.
When IL-12R1 spectratype analysis was applied to BMDCs,
we observed a dose-dependent increase in the ratio of
(mRNA) il12rb1tm to (mRNA) il12rb1 after a 3-h exposure
to M. tuberculosis (Fig. 5 A). In contrast (mRNA) il12rb1
remains the dominant transcript in unstimulated DCs for up
to 6 h (Fig. 5 A). Western blot analysis demonstrated that
IL-12R1 is the dominant protein product in unstimulated
cells, whereas IL-12R1TM increases in abundance after
M. tuberculosis stimulation (Fig. 5 B). That IL-12R1TM
could locate in the membrane was indicated by Western blot
analysis of cellular fractions (Fig. S1 H). Thus, analysis of
mRNA and Western blot analysis confirm that DCs
increase the expression of il12rb1tm and production of
IL-12R1TM after exposure to M. tuberculosis.
To assess the specificity of (mRNA) il12rb1 splicing in
response to M. tuberculosis, we stimulated DCs with a variety
of other microbial and cytokine stimuli. Specifically, DCs
were stimulated with Mycobacterium avium and Yersinia pestis at
an identical MOI, as well as with M. avium cell wall extract,
Escherichia coli LPS, TNF, IL-12, and IL-12(p40)2; production
of IL-12R1TM was subsequently assessed by IL-12R1
Spectratype analysis. Both M. avium and Y. pestis were capable of activating DCs as measured by IL-12p40 production
(Fig. S2 A). As shown in Fig. S2 B, over a 6-h incubation
M. avium was capable of eliciting IL-12R1TM production with kinetics that were similar to that elicited by
M. tuberculosis. This was also observed with M. avium cell wall
extract (Fig. S2 C). Stimulation with Y. pestis and purified
LPS (Fig. S2, D and E) failed to generate IL-12R1TM
over the same 6-h period. Production of IL-12R1TM
protein was also not observed after stimulation of DCs with

varying Y. pestis MOI (Fig. S2 I). Negative results were also
obtained with TNF, IL-12, and IL-12(p40)2–stimulated DCs
(Fig. S2, F–H). Thus, DCs increase the expression of
il12rb1tm in response to M. tuberculosis and the related
organism M. avium, but not upon stimulation with Gramnegative Y. pestis, purified LPS, and cytokines TNF, IL-12,
and IL-12(p40)2.
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known inducers of DC IL-12R1 expression (Nagayama
et al., 2000). We then assessed the relative levels of transcripts
for IL-12R1 isoforms 1 and 2 using specific primers; cDNA
from CD3+ PBMCs was used as a positive control. All samples expressed IL-12R1 when assayed with primers that
recognized both isoforms 1 and 2 (Fig. S3 C, top). However,
amplification with primers specific to either isoform 1
(Fig. S3 C, middle) or isoform 2 (Fig. S3 C, bottom) revealed

that these two transcripts were differentially expressed
depending on the stimulus. Specifically, the production of
isoform 2 was strongly associated with exposure to LPS,
IL-1, IL-2, and CCL3. Stimulation of human DCs with M.
tuberculosis also elicited expression of IL-12R1 isoform 2
over a 6-h time course (Fig. S3 D). We conclude from these
experiments that human DCs, like mouse DCs, respond to
specific stimuli by splicing the IL-12R1 transcript.
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Figure 6. IL-12R1TM is expressed in the M. tuberculosis-infected lung. C57BL/6 mice were aerogenically infected with 100 CFU M. tuberculosis.
At the indicated times after infection the lungs of both (A) uninfected and (B) infected mice were harvested for IL-12R1 spectratype analysis. Shown are
representative spectra from (A) one individual uninfected mouse at each indicated time point or (B) two individual M. tuberculosis-infected mice from each
time point. The numbers adjacent to peaks of an individual IL-12R1 spectra indicate the relative ratio of that peak’s area (the smaller peak representing
IL-12R1TM) to the area of the larger peak that represents IL-12R1. (C) The ratio of IL-12R1TM to IL-12R1 expressed in the lung of uninfected and M.
tuberculosis-infected animals. (D) The ratio of IL-12R1TM to IL-12R1 expressed in the liver of uninfected and M. tuberculosis-infected animals. Data points
in C and D represent the mean and SD of the IL-12R1TM to IL-12R1 ratios expressed in 4–8 individual mice per time point and are combined from two
separate experiments; for the difference between infected lungs relative to uninfected lungs, *, P < 0.05; **, P < 0.005, as determined by Student’s t test.
JEM VOL. 207, March 15, 2010
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il12rb1 was performed. As with M. tuberculosis, we observed a
shift in the ratio of (mRNA) il12rb1tm to (mRNA) il12rb1
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(mRNAs) il12rb1 and il12rb1tm are expressed by CD11c+
cells in the M. tuberculosis–infected lung
We next asked whether (mRNA) il12rb1tm is expressed in
response to M. tuberculosis infection in vivo. To assess this, a
time course of (mRNA) il12rb1tm abundance relative to
(mRNA) il12rb1 in mice aerogenically infected with M. tuberculosis was performed. In uninfected controls, the expression of (mRNA) il12rb1tm was minimal over the entire
30-d period, with (mRNA) il12rb1 being the dominant transcript observed (Fig. 6 A). In M. tuberculosis–infected animals,
however, a shift in the ratio of (mRNA) il12rb1tm to
(mRNA) il12rb1 in the lung is observed at 9 d after infection
(Fig. 6 B), with (mRNA) il12rb1tm reaching 2.3-fold higher
in abundance than (mRNA) il12rb1 in some cases. After
9–12 d, the ratio of (mRNA) il12rb1tm to (mRNA) il12rb1
in the lung diminished, but still remained higher than that of
uninfected controls up to day 30. This result was observed in
several independent experiments (Fig. 6 C). In the liver, an
organ distal to the initial site of infection, we observed
elevated baseline levels of (mRNA) il12rb1tm expression
compared with the lung (Fig. 6 D); however, these levels remained unchanged through the early course of M. tuberculosis
infection (Fig. 6 D). In summary, (mRNA) il12rb1tm is
expressed subsequent to M. tuberculosis infection in vivo—the
relative ratio to (mRNA) il12rb1 being dependent on time
after infection.
The expression of IL-12R1TM by DCs in vitro (Fig. 5)
and by the M. tuberculosis–infected lung in vivo (Fig. 6)
prompted us to determine whether CD11c+ cells from
M. tuberculosis–infected lungs are the source of this transcript.
To do this, CD11c+ cells from the lungs of M. tuberculosis–
infected mice were isolated by magnetic beads at various time
points after infection and expression of (mRNA) il12rb1tm
was determined as described in Fig. 6. CD11c+ cells from M.
tuberculosis–infected mice consistently expressed a higher ratio
of (mRNA) il12rb1tm to (mRNA) il12rb1 compared with
those isolated from uninfected controls, the highest being
observed at 7–12 d after infection (compare top panels of
Fig. 7, A and B). Notably, the CD11c cells from M. tuberculosis–infected mice also expressed a higher ratio of (mRNA)
il12rb1tm to (mRNA) il12rb1 compared with uninfected
controls, the highest being observed at 20 and 30 d after
infection (compare bottom panels of Fig. 7, A and B). This
result was observed in several independent experiments
(Fig. 7 C-D). These data demonstrate that after low-dose
aerogenic M. tuberculosis infection, lung CD11c+ cells exhibit
increased expression of (mRNA) il12rb1tm and that CD11cneg
cells can also express this transcript as infection progresses.
Similar to M. tuberculosis, M. avium and Y. pestis are lungtropic intracellular pathogens. Because exposure to M. avium,
but not Y. pestis, increased DC expression of (mRNA)
il12rb1tm, we next determined if (mRNA) il12rb1tm was
also expressed in the M. avium– or Y. pestis–infected lung. For
this, mice were aerogenically infected with M. avium (Fig. S4 A)
or intranasally with Y. pestis KIMD27 (Fig. S4 C) and a time
course of (mRNA) il12rb1tm abundance relative to (mRNA)

Figure 7. Lung CD11c+ and CD11c- populations increase
IL-12R1TM expression after M. tuberculosis infection. C57BL/6
mice were aerogenically infected with 100 CFU M. tuberculosis. At the
indicated times after infection lung CD11c+ and CD11c- populations were
magnetically separated from both (A) uninfected and (B) infected mice.
Subsequently generated cDNA was used for IL-12R1 spectratype analysis. Shown are representative spectra expressed by CD11c+ and CD11c- cells
from (A) an individual uninfected mouse at each time point or (B) an individual M. tuberculosis—infected mouse at each time point. The numbers
adjacent to peaks of an individual IL-12R1 spectrum indicate the relative
ratio of that peak’s area (the smaller peak representing IL-12R1TM) to the
area of the larger peak that represents IL-12R1. Spectra are representative
of four mice per time point. (C) The ratio of IL-12R1TM to IL-12R1 expressed by lung CD11c+ cells from uninfected and M. tuberculosis—infected
animals. (D) The ratio of IL-12R1TM to IL-12R1 expressed by lung
CD11c- cells from uninfected and M. tuberculosis-infected animals. Data
points in (C and D) represent the mean and SD of the IL-12R1TM to IL12R1 ratios expressed in four individual mice per time point; for the difference between the indicated populations from infected lungs relative to
uninfected lungs, *, P < 0.05, as determined by Student’s t test.
Splicing of il12rb1 alters DC migration | Robinson et al.
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in the lung at 8 d after infection with M. avium (Fig. S4 B).
Despite similar numbers of CFU at 4 d after infection, only
one out of five Y. pestis–infected animals showed expression
of (mRNA) il12rb1tm (Fig. S4 D, top). Negative results
were also obtained upon infection with the more immunostimulatory strain Y. pestis KIMD27/pLpxL (Robinson et al.,
2008; Fig. S4 D, bottom). Thus, although M. tuberculosis (Fig. 6)
and M. avium induce expression of (mRNA) il12rb1tm in
the lungs, Y. pestis does not.
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DISCUSSION
DCs are pivotal for initiating immunity to M. tuberculosis and
other diseases of the pulmonary tract (Tian et al., 2005;
Lambrecht, 2008), and they have been shown to transport
M. tuberculosis from the lungs to the MLN (Wolf et al., 2007).
IL-12 family members are secreted by DCs after Mtb stimulation (Jang et al., 2008) and are required for their ability to
generate an efficient T cell response (Zhang et al., 2003;
Khader et al., 2006). Here, we demonstrate that after their
encounter with M. tuberculosis, DCs express IL-12R1
and an IL-12R1 splice variant that we have termed
“IL-12R1TM.” In contrast to IL-12R1, IL-12R1TM
contains an altered C-terminal sequence and lacks a transmembrane domain; nevertheless, IL-12R1TM is still
membrane associated. Selective reconstitution of il12rb1/
DCs with IL-12R1 and/or IL-12R1TM demonstrates
that IL-12R1TM augments IL-12R1-dependent DC
migration; however, it cannot substitute for IL-12R1. Importantly, after M. tuberculosis infection of the lung, CD11c+
cells in this organ express IL-12R1TM. Further, reconstitution of il12rb1/ DCs with IL-12R1 and IL-12R1TM
accelerates in vivo CD4+ T cell activation compared with
il12rb1/ DCs reconstituted with IL-12R1 alone. Thus,
we propose that in response to M. tuberculosis DCs express
IL-12R1TM, a novel positive regulator of IL-12R1–
dependent signaling, and that this enhances IL-12R1–
dependent migration and M. tuberculosis–specific CD4+ T
cell activation.
Alternative splicing is emerging as an important regulator
of immunity (Lynch, 2004). It is estimated that >75% of
human genes undergo alternative splicing, many of which are
exclusively expressed by the immune system (Johnson et al.,
2003). The list of proteins regulated by splicing includes those
involved in intracellular signaling cascades (i.e., Fyn and Syk),
membrane adhesion (i.e., CD31, CD44, and CD54), and cell
activation (i.e., CD45 and CD152; Lynch, 2004). Alternatively spliced cytokine receptors can regulate inflammatory
events by functioning as either agonists or antagonists of
cytokine signaling (Levine, 2004). The list of alternatively
599
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IL-12R1TM enhances IL-12R1–dependent migration
DCs exhibit IL-12(p40)2– and il12rb1–dependent migration
in response to M. tuberculosis after only a 3-h exposure to this
organism (Fig. 1 C; Khader et al., 2006; Robinson et al.,
2008). Given that (mRNA) il12rb1tm is generated and
translated within this timeframe (Fig. 5), we investigated
whether IL-12R1TM contributed to M. tuberculosis–
induced, IL-12(p40)2–dependent DC migration. To do this,
we selectively restored mRNAs that encode IL-12R1,
IL-12R1TM, or both IL-12R1 and IL-12R1TM to
il12rb1/ DCs, which contain a genomic neo insertion that
disrupts exons 1–3 of the il12rb1 locus (Wu et al., 1997) and
thus lack both these proteins (Fig. 4). We co-transfected GFP
encoding mRNA with the specific mRNAs via electroporation and found that an antibody specific for the common extracellular portion of the IL-12R1 and IL-12R1TM
only labeled GFP+ CD11c+ cells if mRNAs for either
IL-12R1 or IL-12R1TM were delivered to the
il12rb1/ DCs (Fig. 8, A and B). After stimulation with M.
tuberculosis, il12rb1/ DCs transfected with GFP and
IL-12R1 were capable of migrating toward CCL19 whereas
those transfected with GFP alone were not (Fig. 8 C).
il12rb1/ DCs transfected with GFP and IL-12R1TM
had migratory levels equivalent to those transfected with GFP
alone. However, cotransfection with GFP, IL-12R1 and
IL-12R1TM resulted in a greater chemotaxis index than
when DCs were transfected with GFP and IL-12R1. The
majority of migrated cells were GFP+, suggesting that
migration required transfection of the migrating cell and was
not an indirect effect (Fig. 8 D). These data demonstrate
that IL-12R1TM can enhance IL-12R1–dependent
DC migration.
Finally, given that IL-12R1TM enhanced IL-12R1dependent DC migration in vitro, we determined whether
its expression in DCs accelerated the activation of M. tuberculosis-specific T cells in vivo. il12rb1/ BMDCs were selectively restored with mRNAs for IL-12R1, IL-12R1TM,
or both IL-12R1 and IL-12R1TM as described in
Fig. 8. After their electroporation and overnight culture, DCs
were cultured with irradiated M. tuberculosis and ESAT1-20
peptide for 3 h. After this period, DCs were washed and
instilled via the trachea into the lungs of C57BL/6 mice that
had previously received 5 × 106 CFSE-labeled ESAT-TCR
CD4+ cells. 12 h after DC instillation, the surface expression
of CD44 and CD69 by CFSE+CD4+ cells in the draining
MLN was assessed by flow cytometry. As anticipated, mice

that received sham electroporated il12rb1/ DCs had fewer
activated M. tuberculosis–specific T cells in the draining MLN
relative to those that received sham electroporated C57BL/6
DCs (Fig. 8 E). Restoration of IL-12R1 alone to il12rb1/
DCs elevated the frequency of CD44hi and CD62Llo M. tuberculosis–specific T cells; however, restoring IL-12R1TM
alone to il12rb1/ DCs did not elevate the frequency of
activated M. tuberculosis-specific T cells. Importantly, only
when both IL-12R1 and IL-12R1TM were restored to
il12rb1/ DCs did the frequency of activated M. tuberculosisspecific T cells return to the level seen in mice that received
C57BL/6 DCs. This result was observed across several
independent experiments (Fig. 8, F and G). These data demonstrate that IL-12R1TM can enhance IL-12R1–
dependent DC migration from the lung and activation of M.
tuberculosis–specific T cells in the lung draining MLN.

Published March 8, 2010

Downloaded from jem.rupress.org on September 13, 2011
Figure 8. IL-12R1TM enhances IL-12R1-dependent migration. (A–D) il12rb1/ CD11c+ BMDCs were transfected with mRNAs encoding either GFP, GFP and IL-12R1, GFP and IL-12R1TM, or GFP and IL-12R1 and IL-12R1TM. 24 h later, (A) cells were analyzed by flow cytometry for
GFP expression among CD11c+ cells and (B) expression of transfected IL-12R1 was examined by gating on GFP+CD11c+ cells. (C) The migratory ability of
DCs transfected with the indicated mRNAs was assessed as performed in Fig. 1 C. Data points represent the mean and SD of the combined data from
three separate experiments with different BM preparations per experiment. For the difference between CI induced in the indicated groups, *, P < 0.05, as
determined by Student‘s t test. (D) Flow cytometric analysis of those cells that had migrated and transfected with GFP and IL-12R1 and IL-12R1TM
demonstrates that the migratory DCs from this group were mostly GFP+. (E) We compared the ability of il12rb1/ DCs transfected with indicated mRNAs
to activate M. tuberculosis-specific T cells in vivo; sham-transfected C57BL/6 DCs were used as a positive control. After transfection the indicated DCs
600
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IL-12R1–deficient DCs have a reduced M. tuberculosis–
dependent NF-B activation and that IL-12(p40)2 can induce
NF-B activation alone and augment M. tuberculosis–dependent
NF-B activation. Because it lacks any known intracellular
signaling capacity, IL-12R1TM may enhance IL-12R1–
mediated NF-B activation by increasing the affinity of
IL-12(p40)2 for IL-12R1 or by forming some other structure that favors IL-12(p40)2–dependent signaling. In particular, as IL-12p40 binds only to dimer/oligomers of IL-12R1
(Chua et al., 1995), it is possible that the IL-12R1TM
stabilizes oligomerization of IL-12R1. Although it is possible that the splice variant may be secreted into the supernatant, we have not been able to detect it in this fraction, even
after 10-fold concentration, which leads us to postulate that
the splice variant acts at the membrane. Future investigations
in our laboratory will test this idea, as well as determine how
IL-12R1TM remains membrane-associated despite the
absence of a TM-domain.
A large body of data demonstrates the essential function
that the IL12RB1 gene serves in humans to positively
regulate immunity to mycobacterial pathogens. The association between IL12RB1 deficiency and mycobacterial susceptibility undoubtedly reflects the importance of the IL12RB1
gene to a wide variety of cell types. The expression of
IL-12R1 mRNA is increased during active pulmonary
tuberculosis in humans (Taha et al., 1999); expression of
human IL-12R1TM during pulmonary tuberculosis has
never been assessed. Although this study has focused on the
importance of il12rb1 to DC function after their exposure to
M. tuberculosis, our data present a novel pathway whereby a
deficiency in IL-12R1TM results in an impaired DC
function and reduced T cell activation. The generation of a
mouse specifically lacking IL-12R1TM but not IL-12R1
is underway, and this will further our understanding of this
important pathway.
MATERIALS AND METHODS
Mice. All mice were bred at the Trudeau Institute and were treated according to National Institutes of Health and Trudeau Institute Animal Care and
Use Committee guidelines. All animal protocols were approved by the
Trudeau Institute Animal Care and Use Committee. C57BL/6, B6.129S1Il12btm1jm/J (i.e., il12b/ mice; Magram et al., 1996), B6.129S1-Il12rb2tm1jm/J
(i.e., il12rb2/ mice; Wu et al., 2000), and B6.FVB-Tg(Itgax-DTR/
EGFP)57Lan/J (i.e., CD11c-DTR; Jung et al., 2002) mice were originally
purchased from The Jackson Laboratory. C57BL/6 mice deficient of the
B6.129S1-Il12rb2tm1jm/J (il12rb1/ mice) have been previously described
(Wu et al., 1997), as have ESAT61-20-specific TCR-transgenic mice (Reiley
et al., 2008).
Cell preparations. M. tuberculosis infections were performed and the lung
tissue and lymph nodes were processed as described previously (Khader
et al., 2007). Single-cell suspensions were prepared from either digested lung

populations were cultured with M. tuberculosis and ESAT1-20 peptide; after this they were instilled via the trachea into C57BL/6 mice containing transferred CFSE-labeled ESAT-specific CD4+ cells. Shown are histograms of CD44 and CD69 expression on CFSE+CD4+ 12 h later in the draining MLN. Each
histogram is representative of four mice per condition. (F and G) The combined (F) CD44 and (G) CD69 data gated on CFSE+CD4+ in the draining MLN are
shown; these data are representative of two independent experiments with three to four mice per group.
JEM VOL. 207, March 15, 2010
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spliced cytokine receptors include members of the class I
cytokine receptor superfamily (IL-4R, IL-5R, IL-6R, IL7R, IL-9R, EpoR, GCSFR, GMCSFR, gp130, and LIFR),
class II cytokine receptor superfamily (IFNAR1 and IFNAR2), IL-1/TLR family (IL-1RII and IL-1RAcP), TGF
receptor family (TRI and activin receptor-like kinase 7), and
TNFR superfamily (TNFRSF6/Fas/CD95, TNFRSF9/
4-1BB/CD137, and IL-17R; Levine, 2004).
To this list of spliced and functioning cytokine receptors
we can now add IL-12R1TM. The mouse IL-12R1 and
IL-12R1TM cDNAs were originally cloned based on
their nucleotide homology to human IL-12R1 (Chua et al.,
1995). When transfected into COS cells, both cDNAs produced proteins that bind [125I]IL-12 with similar low affinities, suggesting that IL-12R1 and IL-12R1TM were
both expressed on the cell surface (Chua et al., 1995).
However, no function had or has been ascribed to IL12R1TM since that time. Here, we have demonstrated
that although mouse IL-12R1TM cannot substitute for
IL-12R1, it can function in DCs to enhance IL-12(p40)2–
and IL-12R1–dependent migration. That this may be relevant to our understanding of human DC biology is suggested
by our observation that human PBMC-derived DCs also respond to stimulation by splicing (mRNA) IL12RB1 to generate a protein with similar characteristics as the mouse
variant. Curiously, for humans, the stimuli that elicit (mRNA)
IL12RB1 splicing are broader in origin than for mice.
Whether human IL-12R1TM performs the same function in human DCs should certainly be investigated. It should
be mentioned that IL-12R1TM expression is likely not
restricted to DCs and may augment functions other than migration. The expression of (mRNA) il12rb1 and (mRNA)
il12rb1tm in the CD11cneg fraction of M. tuberculosis–
infected lungs suggests that the proteins encoded by these
sequences may play a role during the chronic stage of infection. Whether IL-12R1TM functions to enhance
IL-12R1–dependent processes in T and NK cells is a focus
of future investigations.
Further questions raised by the data include which signaling pathways are required in order for (mRNA) IL-12R1
to be spliced? Our data demonstrate that for mouse DCs,
both M. tuberculosis and M. avium elicit (mRNA) IL-12R1
splicing, whereas Y. pestis stimulation does not; this despite
the fact that Y. pestis does induce DC migration (Robinson et
al., 2008). This suggests that although induction of (mRNA)
il12rb1 is sufficient for DC migration, the augmented migration resulting from induction of (mRNA) il12rb1tm is a
unique aspect of mycobacterial activation of DCs. We have
begun to address the molecular mechanism by which
IL-12R1TM augments DC migration and show that
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resuspended at 20 × 106 cells/ml in cDMEM, and 1 ml of splenocytes
was plated in 6-well dishes (Corning, Inc.) along with 1 ml of 10 µg/ml
Concanavalin A in cDMEM solution (Sigma-Aldrich) for a final concentration
of 5 µg/ml Concanavalin A. Cultures were maintained at 37°C at 10% CO2
for 3 d before cells were harvested for RNA and/or protein as indicated.

BMDCs. BMDCs were generated from BM of 4–5-wk-old C57BL/6 mice
harvested via perfusion of the femur and tibia medullary cavities with ice
cold DMEM. Marrow suspensions were pelleted and incubated in Geys
solution to lyse red blood cells, and the marrow was then resuspended
at 4 × 105 cells/ml in complete supplemented DMEM (cDMEM). 5 ml of
BM homogenate was plated in a Petri dish (Corning, Inc.) along with 5 ml
of 40 ng/ml recombinant murine GM-CSF (Peprotech) in cDMEM solution for a final concentration of 20 ng/ml GM-CSF. Cultures were maintained at 37°C at 10% CO2 for 3 d, at which time an additional 10 ml of
20 ng/ml GM-CSF in cDMEM was added. At 6 d, nonadherent cells were
collected and the presence of CD11c+ cells confirmed by flow cytometric
analysis. For indicated experiments CD11c+ cells were positively selected by
magnetic purification. In these cases 106 CD11c+ cells were placed in a 2 ml
culture with or without indicated concentrations of M. tuberculosis,
Y. pestis, M. avium, TNF, IL-12, or IL-12(p40)2 in cDMEM for varying
amounts of time at 37°C and 10% CO2. After this period, cells were
collected and either lysed for RNA and/or protein as indicated or used for
chemotaxis measurements.

RNA purification and cDNA synthesis. Total RNA was isolated from
indicated tissues and/or cell populations using the RNeasy method
(QIAGEN) and was treated with DNase (Ambion). cDNA was subsequently
synthesized using SuperScript II reverse transcription PCR kit (Invitrogen)
with random hexamer primers.

Flow cytometry. All antibodies used for flow cytometric analysis were
purchased from BD or eBioscience. Experimental cells were washed with
FACS buffer (2% FCS in PBS), FC receptors were blocked using anti-CD16/
CD32 (BD; clone 2.4G2) for 15 min and cells were stained with antibodies
that recognize CD11c (clone HL3), I-Ab (clone AF6-120.1), and IL-12R1
(CD212, clone 114). For all surface markers, positive staining was established
using appropriate isotype controls. Data were acquired using a FACSCalibur
(BD) and analyzed with FlowJo software (Tree Star, Inc.).
In vitro chemotaxis measurement. BMDCs were activated with indicated concentrations of irradiated M. tuberculosis and their ability to respond
to the chemokine CCL19 (25 ng/ml; R&D Systems) was determined using
the previously described in vitro transwell chemotaxis assay (Khader et al.,
2006).
In vivo tracking of lung CD11c+ DCs. C57BL/6, il12b/, il12rb1/, and
il12rb2/ mice received a suspension of 5 µg of irradiated M. tuberculosis in a
5-mM CFSE (Invitrogen) solution delivered via the trachea. 18 h after instillation, the draining MLNs were harvested, and single-cell suspensions were
prepared. Flow cytometry was used to determine the frequency and total
number of CFSE-labeled CD11c+ cells that had accumulated within the MLN.
BM chimeras. To generate mice in which only CD11c+ cells were
deficient of il12rb1, we generated mixed BM chimeras comprising of irradiated C57BL/6 hosts reconstituted with 75% CD11c-DTR/25% il12rb1/
BM. Intraperitoneal injection of DT (resuspended in sterile PBS) should
theoretically remove CD11c+ cells expressing the DTR leaving in this case
only il12rb1/ CD11c+ cells. In brief, 6–10 wk old C57BL/6 hosts were
lethally irradiated with 950 Rads (i.e., a split dose of 475 Rads each, 4 h
apart). The irradiated hosts then received 107 whole BM donor cells comprising either 75% CD11c-DTR/25% il12rb1/ BM or 75% CD11cDTR/25% C57BL/6 BM as a control. BM was prepared as described in the
BMDCs section. Mice were allowed at least 6 wk to reconstitute. Before
ESAT1-20/M. tuberculosis instillation, all mice received an i.p. injection of
4 ng DT/g of body mass to ablate DTR-transgenic CD11c+ cells.
Cell culture. For the generation of Concanavalin A blasts, C57BL/6 spleens
were dispersed through a 70-µm nylon cell strainer (BD) and the cellular
homogenate was pelleted (270 g, 6 min at 4°C) and resuspended in 2 ml of
Geys solution to remove red blood cells. Splenocytes were washed and
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PCR. To amplify the IL-12R1 transcript, we used primer pairs that
selectively amplify the extracellular, transmembrane, or intracellular encoding portions. The relative positions of these primers (labeled P1-P6) are
illustrated in Fig. 3 B. P1–4 sequences are taken directly from a previous
study of IL-12R1 expression in DCs (Grohmann et al., 1998). The 5-3
sequences of these and the other primers used in our study are as follows: P1,
5-TATGAGTGCTCCTGGCAGTAT-3; P2, 5-GGCATGCTCCAATCACTCCAG-3; P3, 5-AATGTGCTCGCCAAAACTCG-3; P4, 5GCCAATGTATCCGAGACTGC-3. Primer P5 was designed for this
study; its sequence is as follows: 5-CTGCCTCTGCCTCTGAGTCT-3.
IL-12R1 transcripts were amplified by PCR in a 25-µl reaction comprising
the following: 2.5 µl of a 10× PCR buffer (200 mM Tris, pH 8.4, 500 mM
KCl), 0.5 µl of 10 mM dNTPs, 1 µl 50 mM MgCl2, 0.1 µl of 5 U/µl Taq
polymerase (Invitrogen), 1 µl of 5 µM forward primer (P1 or P3), 1 µl of
5 µM reverse primer (P2, P4 or P5), 17.9 µl of DNase-free H2O, and 1 µl of
cDNA (a minimum of 200 pg cDNA). After denaturation at 94°C for 3 min,
the reaction was cycled forty times under the following conditions: 94°C for
45 s, 60°C for 30 s, and 72°C for 90 s. The products of this reaction were
analyzed on a 2% agarose gel or kept for IL-12R1 spectratype analysis as
described in the following section.
IL-12R1 spectratype analysis. IL-12R1 spectratype analysis of
IL-12R1 and IL-12R1TM mRNAs, and the quantification of the
resultant data, was a modification of the now commonly used TCR-CD3
Spectratype analysis (Pannetier et al., 1993). IL-12R1 and IL-12R1TM
cDNA transcripts were first amplified by PCR in the 25-µl reaction detailed
above with the forward primer 5-CAGCCGAGTAATGTACAAGG-3
and reverse primer 5-CTGCCTCTGCCTCTGAGTCT-3. The forward
primer corresponds to nt 1653–1672 of the mouse IL-12R1 transcript and
precedes the transmembrane-encoding sequence (nt 1739–1834). The
reverse primer is downstream of the transmembrane-encoding sequence,
corresponding to nucleotides 2067–2086 of the mouse IL-12R1 transcript.
To fluorescently label the IL-12R1 and IL-12R1TM amplicons we
performed a second, runoff PCR reaction as follows: 2.5 µl of the initial
amplification reaction was added to 22.5 µl of a second PCR comprising
2.5 µl of 10× PCR buffer, 0.5 uL of 10 mM dNTPs, 1 uL 50 mM MgCl2,
0.1 uL of 5 U/uL Taq polymerase (Invitrogen), 2 uL of a 5 uM FAM-labeled
reverse primer (FAM-5-AGTGCTGCCACAGGGTGTA-3), and 16.4 µl
of DNase-free H2O (final volume: 25 µl). After denaturation at 94°C for
5 min, the reaction was cycled four times under the following conditions:
95°C for 2 min, 55°C for 2 min, 72°C for 20 min. 2 µl of the completed
runoff PCR reaction was then added to 2.0 µl of ROX-500 size standard
(Applied Biosystems) and 36 µl of HiDi Formamide (Applied Biosystems).
After denaturation, the products were detected and their size and relative
amount determined using an Applied Biosystems 3100 sequencer analyzed
with GeneScan software (Applied Biosystems). For calculating the ratio of
IL-12R1TM to IL-12R1 (i.e., IL-12R1TM:IL-12R1) we simply
divided the area under the IL-12R1TM peak by the area under the
reference IL-12R1 peak.
Plasmids and transfections. Plasmids expressing IL-12R1 and
IL-12R1TM cDNAs in vector pEF-BOS (Mizushima and Nagata, 1990)
under the EF1 promoter have been described (Chua et al., 1995;
Splicing of il12rb1 alters DC migration | Robinson et al.
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tissue or lymph nodes by direct dispersal through a 70-µm nylon tissue
strainer (BD). The resultant suspension was treated with Geys solution (155
mM NH4Cl, 10 mM KHCO3) to remove any residual red blood cells,
washed twice with complete media, counted, and stained for subsequent
flow cytometric analysis.
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pEF-BOS.IL-12R1 and pEF-BOS.IL-12R1TM). pAcGFP1-N1
(Takara Bio Inc.) was used to express eGFP under the CMV promoter to
identify transfected cells. For transfection into NIH/3T3 cells (American
Type Culture Collection) we used the Polyfect system (QIAGEN) after the
manufacturers instructions.
Western blot analysis. SDS-PAGE analysis of reduced protein samples and
subsequent transfer to PVDF membrane was performed using standard
protocols. Membranes were subsequently probed overnight with 400 ng/ml
goat polyclonal anti-IL-12R1 (R&D Systems) in a solution of Trisbuffered saline containing 2.5% powdered milk, washed with Tris-buffered
saline, secondarily probed with HRP-conjugated anti-goat IgG and detected
using ECL Western blotting substrate (Thermo Fisher Scientific) for chemiluminescence. For a positive control, recombinant mouse IL-12R1 (R&D
Systems) was run simultaneously with each gel.

NF-B EMSA. Nuclear extracts from indicated cell populations were subjected to polyacrilamide electrophoresis and EMSA analysis of subsequently
generated blots with a NF-B EMSA kit (Panomics) with biotinylated
NF-B probe 5-AGTTGAGGGGACTTTCCCAGGC-3, as per the
manufacturer’s instructions.
In vitro mRNA transcription. To generate in vitro–transcribed (IVT)
mRNA of IL-12R1, IL-12R1TM and eGFP it was first necessary to
subclone their respective cDNAs into a second plasmid, downstream of a T7
phage polymerase. The IL-12R1 and IL-12R1TM cDNAs were first
amplified out of their pEF-BOS backbones using primers that flanked their
start and stop codons; specifically 5-TGTTTCTGAGCGTGGACAAG-3
and 5-CCGCAGTCTTATGGGTCCT-3. eGFP was amplified out of
pAcGFP1-N1 using primers 5-TAGCGCTACCGGACTCAGAT-3
(cognate to the sequence just 5 of the eGFP start codon) and 5-GGGAGGTGTGGGAGGTTTT-3. IL-12R1, IL-12R1TM, and eGFP amplicons were subsequently TA-cloned into pCR2.1 downstream of the T7
phage polymerase promoter to generate the plasmids pCR2.1.IL-12R1,
pCR2.1.IL-12R1TM, and pCR2.1.eGFP, respectively. These constructs
were subsequently used in the mMessage mMachine kit (Ambion) to generate 5 capped IVT mRNA as per the manufacturer’s instruction. mRNA
quality was checked by gel electrophoresis, and the concentration was determined by spectrophotometric analysis at OD260. mRNA aliquots were stored
at 80°C until used for transfections.
Electroporation of DCs. Electroporation of individual mRNAs into
il12rb1/ DCs was done as performed by Ponsaerts et al. (2002), with minor
modifications. In brief, before electroporation, DCs were washed twice with
electroporation buffer (Ambion) and resuspended to a final concentration of
5 × 107 cells/ml in electroporation buffer. Subsequently, 0.2 ml of the cell
suspension was mixed with 20 µg of IVT mRNA and electroporated in a 0.4-cm
cuvette at 300 V and 150 F using a Gene Pulser Xcell Electroporation System
(Bio-Rad Laboratories). After electroporation, fresh complete medium was
added to the cell suspension and cells further incubated at 37°C in a humidified
atmosphere supplemented with 5% CO2. For all electroporation experiments,
the co-transfection of eGFP-mRNA was used to both confirm transfection
efficiency and to identify those cells that have been successfully transfected.
JEM VOL. 207, March 15, 2010

IL-12RB1 isoform expression by human DCs. Monocyte-derived DCs
were generated by incubating magnetically purified CD14+ monocytes from
apheresis samples for 7 d with 20 ng/ml GMCSF (Peprotech) and
50 ng/ml IL-4 (R&D Systems). DCs were then incubated for 24h with 1
µg/ml LPS or for 3 d with either of the following: 10 ng/ml IL-1, 200 ng/ml
IL-10, 10 ng/ml IL-6, 20 U/ml IL-2, 50 ng/ml CCL3, 50 ng/ml PlGF, or
just RPMI media (control). Alternatively, DCs were stimulated with M. tuberculosis over a 6-h period. Subsequently generated cDNA from these populations was then amplified with primer pairs that either amplified both
IL-12RB1 isoforms 1 and 2 (Common: forward, 5-ACACTCTGGGTGGAATCCTG-3; reverse, 5-GCCAACTTGGACACCTTGAT-3), only
isoform 1 (Isoform 1 Specific: forward, 5-ACACTCTGGGTGGAATC
CTG-3; reverse, 5-CACCCTCTCTGAGCCTCAAC-3) or only isoform
2 (Isoform 2 Specific: forward, 5-ACACTCTGGGTGGAATCCTG-3;
reverse, 5-CACTTTGGGAGGCCAAG-3). The conditions used to amplify with these primers were the same as those used for the primary PCR of
IL-12R1 spectratype analysis detailed above. cDNA from CD3+ PBMCs
was used as a positive control for IL-12RB1 expression. Amplicons were
analyzed by 2% agarose gel electrophoresis.
Statistical analysis. Differences between the means of experimental groups
were analyzed with the two-tailed Student’s t test as the data were
considered parametric. Differences with a P value of 0.05 or less were
considered significant. Prism software was used for all analyses.
Online supplemental material. Fig. S1 demonstrates the concept and
validation of IL-12R1 spectratype analysis. Fig. S2 shows that the
expression of IL-12R1TM mRNA by mouse DCs is limited to mycobacterial stimulation. Fig. S3 demonstrates that two isoforms of IL-12R1
are expressed by human DCs after exposure to M. tuberculosis and other
specific stimuli. Fig. S4 shows that lung expression of IL-12R1TM
mRNA also occurs during pulmonary infection with M. avium, but not
Y. pestis. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20091085/DC1.
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